Search results for: 'disease management'

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

22 Aug 2024  |  Global  |  Technology Research

Pipeline Assessment for Cardiovascular Diseases

Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential

Infographics

×

Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been many advancements made to this indication using wearables and advanced diagnostics and devices, growth in therapeutics has been veiled. Traditional pharmacotherapy faces the drawbac...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

Just as global markets show signs of moving on from the disruptions caused by COVID-19, the French economy now faces a period of high inflation and low economic growth. High inflation will act as a tailwind for rising prices and revenues. While this is expected to drive revenue expansion, it will increase costs and put pressure on margins. Franc...

The World Bank estimates that rapid population growth and urbanization have resulted in a global average waste generation of about 0.79 kilograms per citizen per day as of 2022. It predicts a direct relationship between waste generation and income levels and projects the daily per capita waste generation in high-income countries to increase by 19.0...

25 Jan 2022  |  Asia Pacific  |  Market Research

Asia-Pacific Privileged Access Management (PAM) Solution Growth Opportunities

The Sophistication of Threat Landscape and the Increasing Explosion of Identities Drive the Future Growth Potential of Privileged Access Management

Infographics

×

This study assesses the Asia-Pacific Privileged Access Management (PAM) Market from 2020 to 2025. PAM refers to technologies/solutions that help secure, control, manage, and monitor privileged access to critical assets to mitigate risks and maintain productivity. A PAM solution typically falls into two categories: Privileged Password & Session M...